Д.Гантуяа
Loading...
Товч нэр
Д.Гантуяа
Бүтэн нэр
Дорж Гантуяа
Латин нэр
Dorj Gantuya
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Дэд профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
ORCID
5 results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.(2026) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Acceptance of Self-Sampling and Knowledge about Human Papillomavirus among Women in Mongolia(EpiSmart Science Vector Ltd, 2024-05-01); Sambuu, Tsegmed - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial(Elsevier BV, 2024-01) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial(Elsevier BV, 2025-11) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immunogenicity, Safety, and Reactogenicity of a Half- Versus Full-Dose BNT162b2 (Pfizer-Biontech) Booster Following a Two-Dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac Priming Schedule in Mongolia: A Randomised, Controlled, Non-Inferiority Trial(Elsevier BV, 2023)